Hagop Kantarjian

MD Anderson Cancer Center

Guest

Chair of the Department of Leukemia at the University of Texas' MD Anderson Cancer Center in Houston

Hagop Kantarjian on KCRW

One third of all Americans will get some form of cancer during their lifetimes — and the average cost of drug treatment is $100,000 a year.

The Rising Cost of Fighting Cancer

One third of all Americans will get some form of cancer during their lifetimes — and the average cost of drug treatment is $100,000 a year.

from To the Point

More from KCRW

In late September 2020, then-President Trump ordered an end to racial sensitivity training for federal employees, though later President Biden reversed that order.

from Press Play with Madeleine Brand

In Tulsa, Oklahoma, President Biden today marked the 100th anniversary of the Tulsa Race Massacre, and he unveiled new measures to address the racial wealth gap.

from Press Play with Madeleine Brand

Community activists, entrepreneurs, and local politicians are keeping tabs on President Biden’s $2 trillion infrastructure spending plan that’s currently being debated on Capitol Hill.

from Greater LA

For most of American history, abortion has been legal, outlawed only from 1867 to 1973. Now the U.S. Supreme Court might outlaw it again by overturning Roe v. Wade.

from To the Point

Josh Barro and Ken White talk about the first Capitol riot defendant to be sentenced, Ukrainian oligarchs, Bolton’s off the hook for his book and the Trump Organization sues New York…

from All the Presidents' Lawyers

Political fallout is mounting as LA grapples with how to house its many residents living on the streets.

from Press Play with Madeleine Brand

“I want to end the conservatorship ma’am,” pop star Britney Spears told a judge at her latest conservatorship hearing Wednesday in Downtown Los Angeles.

from KCRW Features

With the state’s color-coded reopening tiers riding off into the sunset, there’s no more social distancing, and masks in almost every indoor situation are being retired.

from KCRW Features

The second American Revolution: A work in progress

from Scheer Intelligence